Low anticoagulant activity bovine heparin reduces Lung Lewis Carcinoma pulmonary metastasis on mice model.

Favorite this paper
How to cite this paper?
Details
  • Presentation type: IC - Undergraduate Students
  • Track: 5. Metabolism and Glycobiology
  • Keywords: heparin; coagulation; Câncer; metastasis;
  • 1 Instituto de Bioquímica Médica (IBqM), UFRJ.
  • 2 Laboratório de Tecido Conjuntivo, Instituto de Bioquímica Medica (IBqM), UFRJ.

Please log in to watch the video

Log in
Abstract

INTRODUCTION AND OBJECTIVES: Cancer is an increasingly prevalent disease that affects millions of people annually worldwide. Many efforts have been made by researchers in order to elucidate the mechanisms of this disease and thus to propose new therapeutic and prophylactic measures. Evidence has emerged that the biological effects of heparin are beyond anticoagulant activity. It has been demonstrated to have anti-inflammatory, anti-viral, anti-tumor effects. However, it is not possible to use it for these therapeutic purposes due to its potential hemorrhagic effect. Given this, new molecules have been researched with a view to getting over this obstacle. With this in mind, in our laboratory we were able to purify a fraction of bovine intestinal heparin with low anticoagulant activity (LABH). In this essay, our aim is to test this molecule for anti-metastatic activity. MATERIAL AND METHODS: We used the lung metastasis induced animal model due to intravenous injection into the tail vein of Lung Lewis Carcinoma (LLC) cells, in the amount of 300,000 cells/animal, in C57BL/6 wild type mice 10-12 weeks old. The animals were treated with 1 daily dose of LABH (N =10) at a dose of 20 mg/kg subcutaneously, the first dose occurring 1 hour before the administration of the LLC cells, and compared to the 0.9% saline group (N =11) and a group of healthy animals (N=5). The animals were followed for 3 weeks and, at the end of this period, the animals were sacrificed and the pulmonary metastatic foci counted. RESULTS AND CONCLUSION: During follow-up there was no behavioral change, bleeding or local adverse reactions related to LABH. There was no weight variation in relation to the group of healthy animals. In the pathological analysis by macroscopy, LABH was able to reduce the absolute number of animals affected by metastasis, as well as the number of metastatic foci per animal, expressing a relative risk reduction of 77%. Thus, we concluded that LABH demonstrated safety locally and systemically for multiple doses and also exhibited an effective anti-metastatic action. Further studies in other animal models and with other doses are needed in order to investigate the full potential benefit of this molecule.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!